Effectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency
Angela M Chen,Tawna L Roberts,Susan A Cotter,Marjean T Kulp,Loraine T Sinnott,Eric J Borsting,Yin C Tea,Lisa A Jones-Jordan,Richard Hertle,G Lynn Mitchell,L Eugene Arnold,Christopher Chase,Mitchell M Scheiman,Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART) Investigator Group,Jeffrey Cooper,Erica Schulman,Kimberly Hamian,Danielle Iacono,Steven Larson,Valerie Leung,Sara Meeder,Elaine Ramos,Steven Ritter,Audra Steiner,Alexandria Stormann,Marilyn Vricella,Xiaoying Zhu,Susanna Tamkins,Naomi Aguilera,Elliot Brafman,Hilda Capo,Kara Cavuoto,Isaura Crespo,Monica Dowling,Kristie Draskovic,Miriam Farag,Vicky Fischer,Sara Grace,Ailen Gutierrez,Carolina Manchola-Orozco,Maria Martinez,Craig McKeown,Carla Osigian,Tuyet-Suong Pham,Leslie Small,Natalie Townsend,Michael Gallaway,Mark Boas,Christine Calvert,Tara Franz,Amanda Gerrouge,Donna Hayden,Erin Jenewein,Zachary Margolies,Shivakhaami Meiyeppen,Jenny Myung,Karen Pollack,Ruth Shoge,Andrew Tang,Noah Tannen,Lynn Trieu,Luis Trujillo,Michelle Buckland,Allison Ellis,Jennifer Fogt,Catherine McDaniel,Taylor McGann,Ann Morrison,Shane Mulvihill,Adam Peiffer,Maureen Plaumann,Gil Pierce,Julie Preston,Kathleen Reuter,Nancy Stevens,Jake Teeny,Andrew Toole,Douglas Widmer,Aaron Zimmerman,Carmen Barnhardt,Raymond Chu,Kristine Huang,Susan Parker,Dashaini Retnasothie,Judith Wu,Penny Clark,Kelly Culp,Kathy Fraley,Drusilla Grant,Nancy Hanna,Stephanie Knox,William Lawhon,Lan Li,Sarah Mitcheff,Isabel Ricker,Casandra Solis,Palak Wall,Samantha Zaczyk,Kristine Hopkins,Wendy Marsh-Tootle,Michelle Bowen,Terri Call,Kristy Domnanovich,Marcela Frazier,Nicole Guyette,Oakley Hayes,John Houser,Sarah Lee,Jenifer Montejo,Tamara Oechslin,Christian Spain,Candace Turner,Katherine Weise,Rachel Coulter,Deborah Amster,Surbhi Bansal,Laura Falco,Gregory Fecho,Katherine Green,Gabriela Irizarry,Jasleen Jhajj,Nicole Patterson,Jacqueline Rodena,Julie Tyler,Dana Weiss,Lauren Zakaib,Ingryd Lorenzana,Yesena Meza,Ryan Mann,Mariana Quezada,Scott Rein,Indre Rudaitis,Susan Stepleton,Beata Wajs,Maryann Redford,Carolyn Denton,Sharyl Wee,Katlynn Dahl-Leonard,Kenneth Powers,Amber Alaniz,Marie Diener-West,William V Good,David Grisham,Christopher J Kratochvil,Dennis Revicki,Jeanne Wanzek,Mustafa Abraham,Julianne Dangelo,Jordan Hegedus,Ian Jones,Alexander Junglas,Jihyun Lee,Jadin Nettles,Curtis Mitchell,Mawada Osman,Gloria Scott-Tibbs,Chloe Teasley,Victor Vang,Robin Varghese
DOI: https://doi.org/10.1111/opo.12747
Abstract:Purpose: To determine the effectiveness of office-based vergence/accommodative therapy for improving accommodative amplitude and accommodative facility in children with symptomatic convergence insufficiency and accommodative dysfunction. Methods: We report changes in accommodative function following therapy among participants in the Convergence Insufficiency Treatment Trial - Attention and Reading Trial with decreased accommodative amplitude (115 participants in vergence/accommodative therapy; 65 in placebo therapy) or decreased accommodative facility (71 participants in vergence/accommodative therapy; 37 in placebo therapy) at baseline. The primary analysis compared mean change in amplitude and facility between the vergence/accommodative and placebo therapy groups using analyses of variance models after 4, 8, 12 and 16 weeks of treatment. The proportions of participants with normal amplitude and facility at each time point were calculated. The average rate of change in amplitude and facility from baseline to week 4, and from weeks 4 to 16, were determined in the vergence/accommodative therapy group. Results: From baseline to 16 weeks, the mean improvement in amplitude was 8.6 dioptres (D) and 5.2 D in the vergence/accommodative and placebo therapy groups, respectively (mean difference = 3.5 D, 95% confidence interval (CI): 1.5 to 5.5 D; p = 0.01). The mean improvement in facility was 13.5 cycles per minute (cpm) and 7.6 cpm in the vergence/accommodative and placebo therapy groups, respectively (mean difference = 5.8 cpm, 95% CI: 3.8 to 7.9 cpm; p < 0.0001). Significantly greater proportions of participants treated with vergence/accommodative therapy achieved a normal amplitude (69% vs. 32%, difference = 37%, 95% CI: 22 to 51%; p < 0.0001) and facility (85% vs. 49%, difference = 36%, 95% CI: 18 to 55%; p < 0.0001) than those who received placebo therapy. In the vergence/accommodative therapy group, amplitude increased at an average rate of 1.5 D per week during the first 4 weeks (p < 0.0001), then slowed to 0.2 D per week (p = 0.002) from weeks 4 to 16. Similarly, facility increased at an average rate of 1.5 cpm per week during the first 4 weeks (p < 0.0001), then slowed to 0.6 cpm per week from weeks 4 to 16 (p < 0.0001). Conclusion: Office-based vergence/accommodative therapy is effective for improving accommodative function in children with symptomatic convergence insufficiency and coexisting accommodative dysfunction.